Nanologica AB (publ) (OM: NICA)
Health Care · Biotechnology · SE
Skr0.44
-5.14% today · -69.1% 1Y
Nanologica AB (publ) (OM: NICA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $15.38M and employs 72 people.
Over the last twelve months the share price has lost 69.1%, trading between 0.33 and 2.25.
Tweenvest scores Nanologica AB (publ) across four factors: quality 31/100, value 49/100, growth 100/100. Its strongest factor is growth.
NICA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $15.38M
- Revenue (TTM)
- $3.34M
- P/E
- 1.70
- EPS
- 0.26
- Dividend yield
- —
- Beta (5Y)
- -0.08
- 52-week high
- Skr2.25
- 52-week low
- Skr0.33
- Avg volume (3M)
- —
- Shares outstanding
- 328.77M
- Employees
- 72
- Next earnings
- —
About Nanologica AB (publ)
Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science industry in China, India, the United State of America, and internationally. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA, a pre-packaged columns for analytical chromatography; and high-performance liquid chromatography, a separation method based on different substances in a solution passing through a column at different paces. The company provides products for the analysis and purification of substances, with a focus on peptides drugs for the treatment of diabetes and obesity. Nanologica AB (publ) was incorporated in 2004 and is headquartered in Södertälje, Sweden.
- ISIN
- SE0005454873
- Founded
- 2004
- Listed since
- Oct 30, 2015
- Exchange
- OMX Nordic Exchange Stockholm
- Currency
- SEK
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.